Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl Trimethyl Ammonium Bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with Ethanol FeF® (CAS No. 1119-97-7) consists of approximately 20% dodecyl trimethyl ammonium bromide, approximately 70% trimethyl tetradecyl ammonium bromide and around 10% hexadecyl trimethyl ammonium bromide.
Manufactured in accordance with current good manufacturing practice (cGMP) guideline ICH Q7 for Active Pharmaceutical Ingredients, FeF® is analysed according to meet current British Pharmacopoeia (BP) guidelines.
Packaging sizes:
- Item number: 7800024, 200kg drum
Documentation and services
Novo Nordisk Pharmatech offers a wide range of documentation, including:
- European drug master file (ASMF)
- Good manufacturing practice (GMP) certificate
Certificate of Analysis (current version of Pharmacopoeia) - Datasheets
- Customer audits
- Stability results
- Declarations and statements such as transmissible spongiform encephalopathy (TSE) / bovine spongiform encephalopathy (BSE) statements, residual solvents, genetically modified organism (GMO), allergens and animal testing
- Reach
- Change notification statement
- Pre-filled supplier questionnaire
- Impurity profile
- Description of the manufacturing process
- Process flowchart
- Packaging details
- Quality agreements